David J. Whellan

Active 1999–2023

78
Papers
18,819
Citations
63
h-index
78
i10-index

Citations

Citations per year for David J. Whellan1996: 1 citations2000: 5 citations2001: 3 citations2002: 6 citations2003: 15 citations2004: 26 citations2005: 32 citations2006: 28 citations2007: 30 citations2008: 39 citations2009: 67 citations2010: 103 citations2011: 133 citations2012: 184 citations2013: 188 citations2014: 142 citations2015: 167 citations2016: 187 citations2017: 192 citations2018: 167 citations2019: 615 citations2020: 572 citations2021: 652 citations2022: 522 citations2023: 423 citations2024: 587 citations2025: 290 citations2026: 9 citations1997–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,244 citing papers, 25.3% of this breakdownUnited Kingdom: 679 citing papers, 7.7% of this breakdownItaly: 549 citing papers, 6.2% of this breakdownCanada: 513 citing papers, 5.8% of this breakdownGermany: 432 citing papers, 4.9% of this breakdownNetherlands: 372 citing papers, 4.2% of this breakdownChina: 287 citing papers, 3.2% of this breakdownFrance: 279 citing papers, 3.2% of this breakdownAustralia: 251 citing papers, 2.8% of this breakdownSpain: 242 citing papers, 2.7% of this breakdownSweden: 229 citing papers, 2.6% of this breakdownJapan: 224 citing papers, 2.5% of this breakdown
0%25.3%Other 28.9%

Fields

  • Medicine87.5%
  • Biochemistry, Genetics and Molecular Biology2.5%
  • Engineering2%
  • Immunology and Microbiology1.9%
  • Health Professions1.8%
  • Neuroscience1%
  • Other3.3%

Topics

  • Heart Failure Treatment and Management14.6%
  • Cardiovascular Function and Risk Factors7.8%
  • Cardiac Health and Mental Health5.1%
  • Cardiovascular and exercise physiology4.9%
  • Diabetes Treatment and Management3.5%
  • Cardiac pacing and defibrillation studies2.8%
  • Other61.3%

Coauthors

All papers

Open in search
  1. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , - JAMA 2016 cited by 677

  2. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 547

  3. Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2009 cited by 2,167

  4. Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , - JAMA 2017 cited by 538

  5. Efficacy and Safety of Spironolactone in Acute Heart Failure

    Authors: , , , , , , , , , , , , , , , , - JAMA Cardiology 2017 cited by 306

  6. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 452

  7. Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 272

  8. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2018 cited by 258

  9. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Michael Felker, Gregg C. Fonarow, Daniel Gennevois, Stephen S. Gottlieb, James A. Hill, Judd E. Hollander, Jonathan G. Howlett, Michael Hudson, Robb D. Kociol, Henry Krum, Aleksandras Laucevičius, Wayne C. Levy, Gustavo Méndez, Marco Metra, Sanjay Mittal, Byung‐Hee Oh, Naveen L. Pereira, Piotr Ponikowski, W.H. Wilson Tang, Supachai Tanomsup, John R. Teerlink, F. Triposkiadis, Richard W. Troughton, Adriaan A. Voors, David J. Whellan, Faı̈ez Zannad, Robert M. Califf - New England Journal of Medicine 2011 cited by 1,235

  10. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial

    Authors: , , , , , , , , , , , , , , , , , - JAMA Cardiology 2020 cited by 139

  11. Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure

    Authors: , , , , , , , , , , , , , , , - JAMA 2009 cited by 734

  12. Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , - JACC Heart Failure 2021 cited by 85

  13. Frailty and Effects of a Multidomain Physical Rehabilitation Intervention Among Older Patients Hospitalized for Acute Heart Failure

    Authors: , , , , , , , , , - JAMA Cardiology 2023 cited by 86

  14. Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction

    Authors: , , , , , , , , - Circulation Heart Failure 2018 cited by 188

  15. Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial

    Authors: , , , , , , , , , - Circulation 2022 cited by 90

  16. Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , - JAMA 2022 cited by 61

  17. Depression and cardiovascular disease: mechanisms of interaction

    Authors: , , - Biological Psychiatry 2003 cited by 508

  18. Cardiovascular Outcomes With Minute Ventilation–Targeted Adaptive Servo-Ventilation Therapy in Heart Failure

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 153

  19. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan - Journal of the American Heart Association 2023 cited by 51

  20. Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure

    Authors: , , , , , , , , , , , , - JACC Heart Failure 2017 cited by 105

  21. Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries

    Authors: , , , - Circulation 2009 cited by 544

  22. Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Cardiac Failure 2015 cited by 350

  23. A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure

    Authors: , , , , , , , , , - JACC Heart Failure 2017 cited by 150

  24. Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 94